Doctor profile · Federal record
Dr. Paul Tuttle, D.O.
Rheumatology Physician (CMS: Rheumatology) · Student in an Organized Health Care Education/Training Program · Green Bay, WI
- NPI 1023243805
- Accepts Medicare
- MIPS 72.0 / 100 · 2023
- 17 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2223 Lime Kiln RD, Ste 1
Green Bay, WI 543116213
(920) 430-8120
fax (920) 430-8122
Credentials & registration
- NPI registered
- May 2009 — 17 yrs on file
- Profile last updated
- April 22, 2025
- Year of graduation
- 2009 — 17 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- Wisconsin #64162-21
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1023243805. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
63,403
Distinct HCPCS
10
Medicare allowed
$1,093,250
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3262 |
Injection, tocilizumab, 1 mg | 32,760 | 22 | $6 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 10,300 | 33 | $13 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 8,375 | 75 | $33 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 8,085 | 31 | $41 | |
J0897 |
Injection, denosumab, 1 mg | 1,621 | 20 | $23 | |
J7050 |
Infusion, normal saline solution, 250 cc | 450 | 170 | $1 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 426 | 249 | $120 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 250 | 106 | $119 | |
A9577 |
Injection, gadobenate dimeglumine (multihance), per ml | 197 | 11 | $2 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 188 | 70 | $59 |
In context: peer comparison
Among 5 peers in Green Bay Rheumatology Physician, average services per provider: 3,191. This provider delivers 20× the peer median.Open Payments
Industry payments received
All-time total
$678
Transactions
36
Manufacturers
10
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 22 | $367.35 | |
| Amgen INC. | 3 | $78.48 | |
| AstraZeneca Pharmaceuticals Lp | 2 | $62.05 | |
| Novartis Pharmaceuticals Corporation | 2 | $37.20 | |
| Lilly USA, LLC | 2 | $29.57 | |
| Ucb, INC. | 1 | $24.79 | |
| Janssen Biotech, INC. | 1 | $22.57 | |
| Genentech USA, INC. | 1 | $21.63 | |
| Sandoz INC. | 1 | $19.07 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $15.18 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
3,720
Patients
1,034
Total drug cost
$2,332,063
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate | Generic | 823 | 223 | $63,667 |
| Methotrexate (Methotrexate Sodium) | Brand | 732 | 214 | $34,712 |
| Prednisone | Generic | 589 | 162 | $6,522 |
| Humira(Cf) Pen (Adalimumab) | Brand | 174 | 22 | $1,822,138 |
| Folic Acid | Generic | 172 | 55 | $818 |
| Alendronate Sodium | Generic | 163 | 48 | $2,045 |
| Leflunomide | Generic | 163 | 39 | $14,001 |
| Gabapentin | Generic | 148 | 33 | $4,063 |
| Omeprazole | Generic | 137 | 46 | $1,943 |
| Sulfasalazine | Generic | 135 | 41 | $4,255 |
Hospital affiliations
Frequently asked questions
What is Dr. Paul Tuttle's medical specialty?
Dr. Paul Tuttle practices Rheumatology Physician in Green Bay, WI.
Where does Dr. Paul Tuttle practice?
Dr. Paul Tuttle practices at 2223 Lime Kiln RD, Green Bay, WI 543116213. Office phone: 9204308120.
What is Dr. Paul Tuttle's NPI?
Dr. Paul Tuttle's National Provider Identifier (NPI) is 1023243805, issued by NPPES.
Does Dr. Paul Tuttle accept Medicare assignment?
Yes. Dr. Paul Tuttle accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Paul Tuttle commonly perform?
Top Medicare-reported procedures in 2023: Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, infliximab, excludes biosimilar, 10 mg (HCPCS J1745). Source: CMS Medicare Physician & Other Practitioners file.